faultfinder 发表于 2025-3-28 15:27:57

http://reply.papertrans.cn/83/8208/820742/820742_41.png

不透气 发表于 2025-3-28 22:22:58

Leonard F. Mausner,Rita F. Straub,Suresh C. Srivastava

钉牢 发表于 2025-3-29 01:41:25

http://reply.papertrans.cn/83/8208/820742/820742_43.png

jabber 发表于 2025-3-29 03:17:56

http://reply.papertrans.cn/83/8208/820742/820742_44.png

祖传财产 发表于 2025-3-29 09:36:59

http://reply.papertrans.cn/83/8208/820742/820742_45.png

Dorsal 发表于 2025-3-29 14:38:08

http://reply.papertrans.cn/83/8208/820742/820742_46.png

Accessible 发表于 2025-3-29 16:39:50

Tumor Markers and Their Relevance in the Design of Radioimmunoimaging Experimentsmor markers may be more constant in their behavior. An excellent summation of the status of such markers in clinical practice has been presented by Colnaghi et al. (1). Our group has been interested in carbohydrate expression on cancer cells which display dramatic changes in the composition and arch

Veneer 发表于 2025-3-29 20:52:03

http://reply.papertrans.cn/83/8208/820742/820742_48.png

招募 发表于 2025-3-30 00:09:36

http://reply.papertrans.cn/83/8208/820742/820742_49.png

GLEAN 发表于 2025-3-30 05:57:45

Sensitivity and Efficacy Indices for Oncologic Data Reportingn experience with metastatic lung and breast carcinoma suggests that these patients commonly have multiple metastatic lesions (e.g., widespread bony metastases). As a result, we wonder why the number of “known” metastases is not significantly greater than the 17 lesions present in the DeLand and Gol
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Radiolabeled Monoclonal Antibodies for Imaging and Therapy; Suresh C. Srivastava Conference proceedings 1988 Springer Science+Business Med